• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Reducing the Risk of Comparator Sourcing

    Clinical Data Management

    Leveraging AI/ML Analytics for Better Clinical Development Decisions

    What is a Manufacturing Ecosystem and Why are They Growing?

    Get Smart: Integrating PAT Data into Existing Biotech Data Infrastructures
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    EUROAPI Invests €50M to Meet Growing Demand for Prostaglandins

    RK Pharma to Receive $200M Investment from PAG

    Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

    TMC Expands Executive Team

    Peli BioThermal Opens Cold Chain Network Station in Southern California
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    EUROAPI Invests €50M to Meet Growing Demand for Prostaglandins

    RK Pharma to Receive $200M Investment from PAG

    Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

    Peli BioThermal Opens Cold Chain Network Station in Southern California

    Purolite Expands Bioprocessing Production Capacity with New U.S. Facility
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Peli BioThermal Opens Cold Chain Network Station in Southern California

    Biocair Partners with TrakCel to Improve Visibility in the Supply Chain

    SpectronRx, RLS Partner to Boost Radiopharmaceutical Pipeline and Supply Chain

    Serialization and the War on Counterfeit Drugs

    Traceability & 2D Barcodes
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    RK Pharma to Receive $200M Investment from PAG

    Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

    Almac Group Global Workforce Hits 7,000 Employees

    Amarna Therapeutics Names Henk Streefkerk CEO

    Trinity Life Sciences Names Leslie Orne CEO
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Regulatory Affairs: Accelerating Drug Development Timelines

    Berkshire Sterile Secures Over $230,000 in Training Grants

    Purification – A Bottleneck for Large-Scale Manufacturing of Oligonucleotide API?

    FDA 2023 Inspection Roadmap: Is “Readiness” in Your Annual Objectives?

    FDA Watch: Are You Suitably Staffed?
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    INCOG BioPharma Services

    Societal CDMO

    Lannett CDMO

    TaiMed Biologics

    U.S. Pharmacopeia (USP)
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    INCOG BioPharma Services

    Societal CDMO

    Lannett CDMO

    TaiMed Biologics

    U.S. Pharmacopeia (USP)
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Halo Pharma Forms Pediatric Center of Excellence

    Will be dedicated to the development, reformulation, and manufacturing of drug products in pediatric dosage forms

    Halo Pharma Forms Pediatric Center of Excellence
    05.10.17
    Halo Pharma has unveiled the formation of its Pediatric Center of Excellence in support of the development and manufacture of dosage forms tailored for pediatric indications. Halo has been working closely with pharmaceutical companies to apply its expertise in formulation sciences and its integrated manufacturing capabilities across a broad range of scales and dosage forms to overcome the challenges in developing pediatric dosage forms (PDFs) of already approved adult dosage forms. Halo provides specialized contract development and manufacturing services that meet the regulatory requirements of the U.S., Canada, and Europe, where Halo Pharma is already manufacturing PDFs for commercial sale through its sponsors.

    Pharmaceutical companies are often asked by the U.S Food and Drug administration to conduct clinical trials for pediatric indications of adult dosage forms. The advantages of developing PDFs include the potential for extended patent protection and to obtain expanded indications in pediatric populations.

    In support of its Pediatric Center of Excellence, Halo Pharma has developed the infrastructure, process trains and equipment needed for efficient, cost-effective, and rapid production of small- to medium-scale cGMP clinical drug products that are used in pediatric clinical studies. Halo Pharma provides technical expertise needed to modify adult dosage forms for pediatric use. This may include reformulation to enable a lower strength or making changes to the adult dosage form to improve patient compliance by making the medication easier to take and/or taste better.

    Halo Pharma has partnered with several pharmaceutical companies already to develop commercially viable PDFs that have received both U.S. and international regulatory approvals. In addition, the company currently has multiple clinical and commercial PDF programs underway. In nearly all cases, developing a PDF from an adult dosage form requires additional product development work. In many cases, it is necessary to provide the PDF in various strengths matched to different pediatric age/weight brackets. Halo Pharma has the capabilities to manufacture batches of PDFs that typically range in scale from 5 Kg to 1000 Kg, with many requiring multiple processing steps.

    “Our formulation development and clinical manufacturing capabilities can support a variety of oral solid and liquid dosage forms suitable for pediatric applications, such as granules produced using fluid bed technology and mini-tablets that can be packaged into stick packs, powder in bottles for reconstitution, and our liquid products, which are typically oral solutions and suspensions that can also be time release-based,” said Lee Karras, chief executive officer, Halo Pharma. “We offer our customers over 40 years of commercial drug manufacturing experience and a proven track record of approvals with regulatory agencies around the world.”
    Related Searches
    • Formulation Development
    • Development
    • canada
    • cGMP
    Suggested For You
    Lonza Breaks Ground on Commercial Drug Product Facility in Stein Lonza Breaks Ground on Commercial Drug Product Facility in Stein
    Mikart Invests in New Liquids and Suspensions Suite Mikart Invests in New Liquids and Suspensions Suite
    DPT DPT
    Lonza Further Invests in Drug Product Manufacturing Capabilities Lonza Further Invests in Drug Product Manufacturing Capabilities
    Boyds Opens US Office in PA Boyds Opens US Office in PA
    Trust, but Verify Trust, but Verify
    Raman Spectroscopy for Pharmaceutical Analysis & Quality Control Raman Spectroscopy for Pharmaceutical Analysis & Quality Control
    Spray Drying: A Proven Approach to Enhance the Solubility of APIs Spray Drying: A Proven Approach to Enhance the Solubility of APIs
    Recro Acquires IRISYS to Expand CDMO Capabilities Recro Acquires IRISYS to Expand CDMO Capabilities
    Pharmaceutical Outsourcing for Oral Development and Manufacturing Pharmaceutical Outsourcing for Oral Development and Manufacturing
    Curtana and Catalent Enter Brain Cancer Drug Partnership Curtana and Catalent Enter Brain Cancer Drug Partnership
    Drug Product Safety and Security Drug Product Safety and Security
    Idifarma Launches Accelerated Pathway for Complex Drugs Idifarma Launches Accelerated Pathway for Complex Drugs
    Almac’s Charnwood Site Receives ISO Certifications Almac’s Charnwood Site Receives ISO Certifications
    Hermes Pharma Announces Spin-out from Hermes Arzneimittel Hermes Pharma Announces Spin-out from Hermes Arzneimittel

    Related Breaking News

    • Breaking News | Facilities | Industry News
      Lonza Breaks Ground on Commercial Drug Product Facility in Stein

      Lonza Breaks Ground on Commercial Drug Product Facility in Stein

      Milestone for the development of Lonza’s first large-scale drug product manufacturing facility based in Stein.
      02.01.23

    • Breaking News | Drug Development | Facilities | Industry News
      Mikart Invests in New Liquids and Suspensions Suite

      Mikart Invests in New Liquids and Suspensions Suite

      Enhances liquid oral drug product development and manufacturing capabilities of complex formulations.
      02.01.23

    • R&D
      DPT

      DPT

      With a specialized focus on semi-solids and liquids, DPT offers pharmaceutical companies the broadest range of capabilities in the industry. From R&D formulation to commercial-scale manufacturing, small batches to large, liquids to emulsions, sterile or non-sterile, we offer clients of all sizes the most effective resources for meeting challenges.
      Stacy London, Senior Manager, Marketing & Communications 12.02.21


    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Lonza Further Invests in Drug Product Manufacturing Capabilities

      Lonza Further Invests in Drug Product Manufacturing Capabilities

      New filling line to process various modalities, including monoclonal antibodies, bioconjugates, viral vectors, and other gene therapy products.
      09.22.21

    • Breaking News | Promotions & Moves
      Boyds Opens US Office in PA

      Boyds Opens US Office in PA

      Welcomes Katy Rudnick as VP and head of US regulatory affairs.
      09.13.21

    Loading, Please Wait..
    Trending
    • SpectronRx, RLS Partner To Boost Radiopharmaceutical Pipeline And Supply Chain
    • Samsung Biologics Accelerates Timeline Of New Fifth Plant
    • Biopharma Layoffs In 1Q23
    • Veeva Business Consulting Expands With New R&D Services
    • CRO Industry Trends & Challenges
    Breaking News
    • EUROAPI Invests €50M to Meet Growing Demand for Prostaglandins
    • RK Pharma to Receive $200M Investment from PAG
    • Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
    • TMC Expands Executive Team
    • Peli BioThermal Opens Cold Chain Network Station in Southern California
    View Breaking News >
    CURRENT ISSUE

    May 2023

    • New Modalities Hog the Limelight
    • Cell and Gene Therapy is Coming of Age
    • Demand Surges for Cell and Gene Therapy Contract Manufacturing
    • Embracing a New Reality
    • Japan: A Unique Opportunity for Regenerative Medicines and Cell & Gene Therapies
    • Single-Use Technologies Enable Biologic Scaling
    • Get Smart: Integrating PAT Data into Existing Biotech Data Infrastructures
    • FTEs in Drug Discovery
    • Digital Transformation in Pharma
    • What is a Manufacturing Ecosystem and Why are They Growing?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Sempera Organics and Alkemist Labs Announce Partnership for Mushroom Testing
    Nektium Expands International Distribution Network for Botanical Extracts
    Kemin Receives Positive EFSA Opinion for BetaVia Pure, its Beta-Glucan Ingredient
    Coatings World

    Latest Breaking News From Coatings World

    PPG’s New Paint for a New Start Initiative to Beautify Schools Worldwide with Colorful Makeovers
    Powder Technology, Inc. Announces New Electrical Coating
    Michelman Chosen as Inaugural Recipient of Innovation Research Interchange (IRI) Excellence Award
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cue Health Nabs FDA's First De Novo Nod for an At-Home COVID Test
    ISO 13485:2016 Certification Granted to Boston BioProducts
    Paul Colvin Joins Ora Inc. as Chief Operating Officer
    Contract Pharma

    Latest Breaking News From Contract Pharma

    EUROAPI Invests €50M to Meet Growing Demand for Prostaglandins
    RK Pharma to Receive $200M Investment from PAG
    Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Estée Lauder Announces Second Edition of Beauty&You Brand Incubator Program
    GetHarley Raises $52 Million in Latest Funding Round
    Refillable Skincare Products Face Hurdles Despite Growing Sustainability Awareness
    Happi

    Latest Breaking News From Happi

    Carrière Frères Introduces Candle Refills as New Sustainability Initiative
    Gen Z Entrepreneur Introduces The Ashley Marie Collection for 4C Hair Types
    The Estée Lauder Companies Expands Beauty&You Competition for Indian Beauty Brands
    Ink World

    Latest Breaking News From Ink World

    Siegwerk’s Center of Excellence in France Receives Facelift
    Epson announces MakeTheSwitch Campaign
    Pigments Market to Reach $26,598 Million by 2022: AMR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Mark Andy reports successful Low Migration Workshop
    Ryback and Ryback Consulting launches Machinery division
    TLMI launches 2023 award programs
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    The Honest Company to Exit Europe, Asia
    TechnoPlants to Exhibit at ITMA
    Andritz Buys 100% Stake in Dan-Web
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthobiologics Market to Top $10.3 Billion by 2030
    Artelon Granted U.S. FDA 510(k) Clearance for FlexBand, FlexPatch & FlexBand Plus
    Synergy Spine Solutions Completes Enrollment in IDE Clinical Trial
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    ASSA ABLOY Receives Clearance from Mexico for HHI Acquisition
    Christoph Ostermann Named Chairman of Heliatek‘s Advisory Board
    Flexible and Printed Electronics Represented at productronica 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login